Skyward Specialty [SKWD] vs Hanover Insurance [THG] Detailed Stock Comparison
Skyward Specialty
NASDAQ
Loading...
Hanover Insurance
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Skyward Specialty wins in 5 metrics, Hanover Insurance wins in 13 metrics, with 0 ties. Hanover Insurance appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Skyward Specialty | Hanover Insurance | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.68 | 11.47 | Hanover Insurance |
| Price-to-Book Ratio | 2.23 | 1.94 | Hanover Insurance |
| Debt-to-Equity Ratio | 13.29 | 24.39 | Skyward Specialty |
| PEG Ratio | 0.73 | 12.69 | Skyward Specialty |
| EV/EBITDA | 9.97 | 9.21 | Hanover Insurance |
| Profit Margin (TTM) | 10.53% | 8.67% | Skyward Specialty |
| Operating Margin (TTM) | 16.15% | 12.54% | Skyward Specialty |
| EBITDA Margin (TTM) | 16.15% | 12.54% | Skyward Specialty |
| Return on Equity | 16.26% | 19.23% | Hanover Insurance |
| Return on Assets (TTM) | 2.81% | 3.00% | Hanover Insurance |
| Free Cash Flow (TTM) | $300.89M | $796.20M | Hanover Insurance |
| Dividend Yield | N/A | 1.59% | N/A |
| 1-Year Return | 24.46% | 27.91% | Hanover Insurance |
| Price-to-Sales Ratio (TTM) | 1.60 | 0.97 | Hanover Insurance |
| Enterprise Value | $1.78B | $6.77B | Hanover Insurance |
| EV/Revenue Ratio | 1.42 | 1.06 | Hanover Insurance |
| Revenue per Share (TTM) | $31 | $178 | Hanover Insurance |
| Earnings per Share (Diluted) | $3.16 | $15.18 | Hanover Insurance |
| Beta (Stock Volatility) | 0.61 | 0.46 | Hanover Insurance |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Skyward Specialty vs Hanover Insurance Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Skyward Specialty | 0.24% | 3.90% | -7.36% | -18.04% | -2.09% | 1.04% |
| Hanover Insurance | 0.87% | 3.54% | 4.65% | 5.16% | 10.41% | 15.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Skyward Specialty | 24.46% | 75.12% | -3.95% | -3.95% | -3.95% | -3.95% |
| Hanover Insurance | 27.91% | 31.54% | 67.36% | 138.18% | 324.18% | 348.44% |
Performance & Financial Health Analysis: Skyward Specialty vs Hanover Insurance
| Metric | SKWD | THG |
|---|---|---|
| Market Information | ||
| Market Cap | $2.01B | $6.23B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 353,030 | 198,300 |
| 90 Day Avg. Volume | 433,613 | 248,253 |
| Last Close | $49.56 | $175.61 |
| 52 Week Range | $37.79 - $65.05 | $133.97 - $178.68 |
| % from 52W High | -23.81% | -1.72% |
| All-Time High | $65.05 (Jun 02, 2025) | $178.68 (Jun 03, 2025) |
| % from All-Time High | -23.81% | -1.72% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.08% |
| Quarterly Earnings Growth | 0.25% | 2.88% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.09% |
| Operating Margin (TTM) | 0.16% | 0.13% |
| Return on Equity (TTM) | 0.16% | 0.19% |
| Debt to Equity (MRQ) | 13.29 | 24.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.23 | $89.59 |
| Cash per Share (MRQ) | $8.67 | $6.82 |
| Operating Cash Flow (TTM) | $374.84M | $857.30M |
| Levered Free Cash Flow (TTM) | $-68,535,872 | $624.16M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.59% |
| Last 12-Month Dividend | $0.00 | $2.65 |
Valuation & Enterprise Metrics Analysis: Skyward Specialty vs Hanover Insurance
| Metric | SKWD | THG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.68 | 11.47 |
| Forward P/E | 15.16 | 12.69 |
| PEG Ratio | 0.73 | 12.69 |
| Price to Sales (TTM) | 1.60 | 0.97 |
| Price to Book (MRQ) | 2.23 | 1.94 |
| Market Capitalization | ||
| Market Capitalization | $2.01B | $6.23B |
| Enterprise Value | $1.78B | $6.77B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.42 | 1.06 |
| Enterprise to EBITDA | 9.97 | 9.21 |
| Risk & Other Metrics | ||
| Beta | 0.61 | 0.46 |
| Book Value per Share (MRQ) | $22.23 | $89.59 |
Financial Statements Comparison: Skyward Specialty vs Hanover Insurance
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SKWD | THG |
|---|---|---|
| Revenue/Sales | $320.80M | $1.65B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $49.80M | $198.80M |
| Income Tax | $10.96M | $41.90M |
| Net Income (Profit) | $38.84M | $157.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SKWD | THG |
|---|---|---|
| Cash & Equivalents | $112.92M | $315.10M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $76.55M | $722.50M |
| Total Shareholders Equity | $850.72M | $3.04B |
| Retained Earnings | $139.18M | $3.31B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SKWD | THG |
|---|---|---|
| Operating Cash Flow | $96.76M | $58.80M |
| Capital Expenditures | $-202,000 | N/A |
| Free Cash Flow | $96.56M | $37.10M |
| Debt Repayment | $0 | N/A |
| Common Stock Repurchase | N/A | $-11.00M |
Short Interest & Institutional Ownership Analysis
| Metric | SKWD | THG |
|---|---|---|
| Shares Short | 825,600 | 498,696 |
| Short Ratio | 1.85 | 1.75 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 353,030 | 198,300 |
| Average Daily Volume (90 Day) | 433,613 | 248,253 |
| Shares Outstanding | 40.13M | 35.90M |
| Float Shares | 37.43M | 35.44M |
| % Held by Insiders | 0.13% | 0.01% |
| % Held by Institutions | 1.02% | 0.92% |
Dividend Analysis & Yield Comparison: Skyward Specialty vs Hanover Insurance
| Metric | SKWD | THG |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $2.65 |
| Last 12-Month Dividend Yield | N/A | 1.59% |
| 3-Year Avg Annual Dividend | $0.00 | $2.79 |
| 3-Year Avg Dividend Yield | N/A | 0.62% |
| 3-Year Total Dividends | $0.00 | $8.38 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |